🔥🐔 BizChicken 🐔🔥

Companies Similar to Eyenovia, Inc.

Sign Up Today!

National Vision Holdings, Inc.

Market Cap: Medium

Employees: Highest

Eyeglasses and contact lenses

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States providing eyeglasses, contact lenses, and optical services through various brands like America's Best and Eyeglass World.

Tags: contact lenses, e-commerce, eye care, eyeglasses, healthcare services, optical retail, optometric services, wearable products

Website

Symbol: EYE

Recent Price: $10.10

Industry: Specialty Retail

CEO: Mr. L. Reade Fahs

Sector: Consumer Cyclical

Employees: 13998

Address: Building 2200, Duluth, GA 30096

Phone: 770 822 3600

Last updated: 2024-12-31

Eyenovia, Inc.

Market Cap: Lowest

Employees: Lowest

Optejet

Eyenovia, Inc. is focused on developing therapeutic solutions for ophthalmic conditions using its proprietary microdose array print platform and Optejet delivery system. It targets conditions like progressive myopia, presbyopia, and mydriasis.

Tags: Optejet, microdosing, mydriasis, myopia, ophthalmic, pharmaceuticals, presbyopia, therapeutics

Website

Symbol: EYEN

Recent Price: $0.11

Industry: Biotechnology

CEO: Mr. Michael M. Rowe

Sector: Healthcare

Employees: 57

Address: 295 Madison Avenue, New York, NY 10017

Phone: 917 289 1117

Leadership

Charles Mather, Chairman of the Board
Ellen Strahlman, MD, MS, Independent Director
Sean Ianchulev, MD, MPH, Director
Michael Geltzeiler, Independent Director
Rachel Jacobson, Independent Director
Ram Palanki, PharmD, Independent Director
Michael Rowe, Director

Last updated: 2024-12-31

Regeneron Pharmaceuticals, Inc.

Market Cap: Highest

Employees: Highest

EYLEA, Dupixent, Libtayo, Praluent, REGEN-COV, Kevzara, Inmazeb

Regeneron Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes medicines for treating various diseases worldwide, including treatments like EYLEA, Dupixent, Libtayo, and more.

Tags: biotechnology, diseases, healthcare, injections, medicines, pharmaceuticals, treatment

Website

Symbol: REGN

Recent Price: $702.59

Industry: Biotechnology

CEO: Dr. Leonard S. Schleifer M.D., Ph.D.

Sector: Healthcare

Employees: 14165

Address: 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707

Phone: 914 847 7000

Leadership

Leonard S. Schleifer, MD, PhD, Board co-Chair, President and Chief Executive Officer
George D. Yancopoulos, MD, PhD, Board co-Chair, President and Chief Scientific Officer
Zoran Berkovic, Senior Vice President, Financial Planning and Analysis
Maya Bermingham, Senior Vice President, Public Policy and Government Affairs
Leonard Brooks, Senior Vice President, Treasurer
John Calabro, Senior Vice President, Internal Audit
Christina Chan, Senior Vice President, Corporate Affairs
Larry Coury, PhD, Senior Vice President, Associate General Counsel
Ryan Crowe, Senior Vice President, Investor Relations & Strategic Analysis
Matthew Everett, Senior Vice President, Global Procurement
Chris Fenimore, Senior Vice President, Finance and Chief Financial Officer
Rick Hall, Senior Vice President, Human Resources
Justin Holko, Senior Vice President, Global Oncology/Hematology Commercial Business Unit
Nouhad Husseini, Senior Vice President, Business Development
Joseph J. LaRosa, Executive Vice President, General Counsel and Secretary
Melissa Lozner, Senior Vice President, Chief Compliance Officer
Marion McCourt, Executive Vice President, Commercial
Bob McCowan, Senior Vice President, IT and Chief Information Officer
Gonzalo Merino, PhD, Senior Vice President, Chief Intellectual Property Counsel and Associate General Counsel
Richard O’Neal, Senior Vice President, Market Access
Sally A. Paull, Executive Vice President, Human Resources
Smita Pillai, Senior Vice President, Culture and DEI and Chief DEI Officer
George Poth, Senior Vice President, Real Estate & Facilities Management
Alessandra Ravetti, Senior Vice President, Associate General Counsel
Kerry Reinertsen, PhD, Senior Vice President, Strategic Alliances
David Snow, Senior Vice President, Global Head, Dupixent Franchise
Mark Volpe, Senior Vice President, Tax
Bola Akinlade, MD, FACP, Senior Vice President, Clinical Development, Immunology and Inflammation
Hanne Bak, PhD, Senior Vice President, Preclinical Manufacturing and Process Development
Aris Baras, MD, Senior Vice President, Regeneron Genetics Center®
Ned Braunstein, MD, Executive Vice President, Regulatory Affairs and Global Patient Safety
Gang Chen, PhD, Senior Vice President, Protein Expression Sciences
Thomas DiCioccio, PhD, Senior Vice President, Pharmacometrics
Benjamin Drosman, Senior Vice President, Global Development Quality & Regulatory Compliance
Gregory Geba, MD, PhD, Senior Vice President, Global Development Scientific Council
Philip Gregory, DPhil, Senior Vice President, Regeneron Cell Medicines
Gary Herman, MD, Senior Vice President, Early Clinical Development and Experimental Sciences
Boaz Hirshberg, MD, Senior Vice President, Clinical Sciences General Medicine
Diana Hughes, MBBS, Senior Vice President, Global Patient Safety
Bari Kowal, Senior Vice President, Development Operations and Portfolio Management
Christos Kyratsous, PhD, Senior Vice President, Research
Johnathan Lancaster, MD, PhD, Senior Vice President, Global Medical Affairs
John Lin, MD, PhD, Senior Vice President, Immuno-Oncology and Head of Bispecifics
Israel Lowy, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Oncology
Lynn Macdonald, PhD, Senior Vice President, Research
Lori Morton, PhD, Senior Vice President, Research
Andrew Murphy, PhD, Executive Vice President, Research
Muriel O'Byrne, PhD, Senior Vice President, International Regulatory Affairs & Head, European Business Office
William Olson, PhD, Senior Vice President, Therapeutic Proteins
Mohammed Shameem, PhD, Senior Vice President, Formulations Development
L. Andres Sirulnik, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Hematology
Randy Soltys, PhD, Senior Vice President, Drug Safety and Pharmacometrics
Neil Stahl, PhD, Executive Vice President, Research and Development
Robert Vitti, MD, Senior Vice President, Clinical Trial Excellence Strategy
Brian Zambrowicz, PhD, Executive Vice President, Functional Genomics and Chief VelociGene® Operations
Rajesh Ahuja, Senior Vice President, Fill/Finish and External Manufacturing
Frederick Austin, Senior Vice President, Quality Control, Raheen
Christine Childrose, Senior Vice President, Human Resources and HR Operations
David Crenshaw, Senior Vice President, Associate General Counsel
Tikiri Dissanayake, Senior Vice President, IOPS Technical Operations
Patrice Gilooly, Senior Vice President, Quality Assurance and Operations
Jennifer McNay, PhD, Senior Vice President, CMC Regulatory Sciences and Industrial Affairs
Niall O’Leary, Senior Vice President and Site Head, IOPS Raheen
Scott Oberman, Senior Vice President, Supply Chain Operations
David Simon, Senior Vice President, IOPS Finance and Business Operations
Daniel Van Plew, Executive Vice President and General Manager, Industrial Operations and Product Supply
Benjamin Yocum, Senior Vice President, Manufacturing Operations
James Wolfe, Senior Vice President, Process Sciences and Drug Product Engineering
Bonnie L. Bassler, PhD, Director
Michael S. Brown, MD, Director
N. Anthony Coles, MD, Chair of the Board
Joseph L. Goldstein, MD, Director
Kathryn Guarini, PhD, Director
Christine A. Poon, Lead Independent Director
Arthur F. Ryan, Director
Huda Y. Zoghbi, MD, Director
Samantha Dickon, Director, Development Program Management
Gervasio Batista, Sr. Scientist, Neuroscience
James K. Gibson, Senior Regional Director, Immunology/Pulmonary
Beth Brause, Director, Field Reimbursement Management
Eric Prendergast, Director, Pricing Strategy
Ashley Neff, Manager, Digital Communications
Shari Loock, Associate Director, Sourcing
Jennifer Davidson Hamilton, VP and Head of Precision Medicine
Yi Zhang, Director, Health Economics & Outcomes Research
Wilson Caldwell III, Director, GCO Vendor & Relationship Management
David Stein, Director, Medical Operations
Regeneron, Corporate
Grant Anicete, Biotech Production Specialist I / IOPS Rensselaer
Mary McKenna, Lead Quality Control Analyst / IOPS Raheen
Ashley Lebby, Lead Senior Biotech Production Specialist / IOPS Rensselaer
Varenka Rodriguez Diblasi, Principal Scientist, Bioinformatics
Jessie Brown, Manager, Integrative Translational Genetics
Gisu Eom, Lead Cloud DevOps Engineer
Carmen Kenworthy, Scientist, Velocigene
Ralph Hazlewood, Sr. Manager, Research Program Management
Brandy Bennett, Sr. Director, R&D Strategy & Operations

Last updated: 2024-12-31

Precision Optics Corporation, Inc.

Market Cap: Lowest

Employees: Low

Microprecision lenses, micro medical cameras, 3D endoscopes

Precision Optics Corporation, Inc. designs, manufactures, and sells specialized optical systems and components, particularly for medical, industrial, and military use, including advanced medical imaging products like endoscopes.

Tags: custom imaging, endoscopes, illumination systems, industrial, medical instrumentation, military, minimally invasive surgery, optics

Website

About | Contact | Careers | About

Symbol: POCI

Recent Price: $4.93

Industry: Medical - Instruments & Supplies

CEO: Dr. Joseph N. Forkey

Sector: Healthcare

Employees: 83

Address: 22 East Broadway, Gardner, MA 01440

Phone: 978 630 1800

Last updated: 2024-12-31

Glaukos Corporation

Market Cap: Highest

Employees: Medium

i Stent, i Stent inject, i Stent inject W, i Stent Infinite, i Dose TR

Glaukos Corporation is a medical technology and pharmaceutical company developing therapies for glaucoma, corneal disorders, and retinal diseases. It offers micro-bypass stents and injectable implants intended to improve intraocular treatment.

Tags: corneal disorders, glaucoma treatment, i Dose TR, i Stent, medical technology, ophthalmic, pharmaceutical, retinal diseases

Website

Symbol: GKOS

Recent Price: $149.51

Industry: Medical - Devices

CEO: Mr. Thomas William Burns

Sector: Healthcare

Employees: 907

Address: 229 Avenida Fabricante, San Clemente, CA 92672

Phone: 949 367 9600

Last updated: 2024-12-31

Bluejay Diagnostics, Inc.

Market Cap: Lowest

Employees: Lowest

Symphony platform, ALLEREYE diagnostic test

Bluejay Diagnostics, Inc. is a diagnostic company that develops and markets products for triage, diagnosis, and monitoring of disease progression in the United States. Their products include the Symphony platform and the ALLEREYE diagnostic test, and they focus on biomarkers for diseases such as myocardial injury and cardiac heart failure.

Tags: ALLEREYE, Symphony platform, biomarkers, diagnostics, disease monitoring, healthcare, medical devices

Website

Symbol: BJDX

Recent Price: $3.85

Industry: Medical - Devices

CEO: Mr. Indranil Dey

Sector: Healthcare

Employees: 10

Address: 360 Massachusetts Avenue, Acton, MA 01720

Phone: 844 327 7078

Last updated: 2024-12-31

EyeGate Pharmaceuticals, Inc.

Market Cap: Lowest

Employees: Lowest

EGP-437

Eye Gate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye.

Tags: EGP-437, clinical stage, drug delivery, eye diseases, pharmaceutical, uveitis

Website

Symbol: EYEG

Recent Price: $35.04

Industry: Biotechnology

CEO: Mr. Stephen From

Sector: Healthcare

Employees: 14

Address: 271 Waverley Oaks Rd Ste 108, Waltham, MASSACHUSETTS 02452

Phone: 17817889043

Leadership

Paul Chaney, Chairman of the Board
Morton F. Goldberg, MD, Director
Praveen Tyle, PhD, Director
Thomas Balland, Director
Thomas E. Hancock, Director
Bernard Malfroy-Camine, PhD, Director
Mounia Chaoui, PhD, Director

Last updated: 2024-12-31

EyePoint Pharmaceuticals, Inc.

Market Cap: Medium

Employees: Low

ILUVIEN, YUTIQ, DEXYCU, EYP-1901, YUTIQ50

Eye Point Pharmaceuticals, Inc. develops and commercializes ophthalmic products for treating eye diseases, including innovative treatments like ILUVIEN, YUTIQ, and DEXYCU. Their efforts serve the United States, China, and the United Kingdom, focusing on diseases such as diabetic macular edema and chronic non-infectious uveitis.

Tags: DEXYCU, ILUVIEN, YUTIQ, biotechnology, eye diseases, eye health, micro-insert, ophthalmic, ophthalmology, pharmaceutical, treatment, vision

Website

Symbol: EYPT

Recent Price: $7.02

Industry: Biotechnology

CEO: Dr. Jay S. Duker M.D.

Sector: Healthcare

Employees: 121

Address: 480 Pleasant Street, Watertown, MA 02472

Phone: 617 926 5000

Last updated: 2024-12-31

IRIDEX Corporation

Market Cap: Lowest

Employees: Low

Cyclo G6 laser system, IQ 532, and IQ 577 laser photocoagulation systems

IRIDEX Corporation is an ophthalmic medical technology company offering laser systems and devices for the treatment of sight-threatening eye diseases like glaucoma, diabetic macular edema, and retinal diseases.

Tags: diabetic macular edema, eye diseases, glaucoma treatment, medical lasers, ophthalmic technology, retinal diseases

Website

Symbol: IRIX

Recent Price: $1.74

Industry: Medical - Devices

CEO: Mr. Patrick Mercer

Sector: Healthcare

Employees: 111

Address: 1212 Terra Bella Avenue, Mountain View, CA 94043

Phone: 650 940 4700

Last updated: 2024-12-31

iTeos Therapeutics, Inc.

Market Cap: Medium

Employees: Low

inupadenant, EOS-448

Iteos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of immuno-oncology therapeutics. Their product pipeline includes inupadenant and EOS-448, which are in various phases of clinical trials.

Tags: biopharmaceutical, clinical trials, immuno-oncology, therapeutics

Website

Symbol: ITOS

Recent Price: $7.29

Industry: Biotechnology

CEO: Dr. Michel Detheux Ph.D.

Sector: Healthcare

Employees: 157

Address: 321 Arsenal Street, Cambridge, MA 02472-5710

Phone: 339 217 0161

Leadership

Michel DETHEUX, President, Chief Executive Officer
Matt CALL, Chief Operating Officer
Matthew GALL, Chief Financial Officer
Yvonne MCGRATH, Chief Scientific Officer
David Feltquate, Chief Medical Officer
Philippe BRANTEGEM, Executive Vice President of Human Resources
Adi OSOVSKY, Executive Vice President of Legal
David HALLAL, Chair of the Board
Aaron DAVIS,
Jill DESIMONE,
David LEE,
Tim VAN HAUWERMEIREN,
Tony HO,
Robert IANNONE,
Ann RHOADS,

Last updated: 2024-12-31

Kala Pharmaceuticals, Inc.

Market Cap: Lowest

Employees: Lowest

KPI-012, EYSUVIS, INVELTYS

Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for eye diseases using proprietary mucus penetrating particles technology.

Tags: biopharmaceutical, corneal epithelial defects, dry eye disease, eye diseases, gene expression, mucus penetrating particles, ocular surgery, retinal diseases

Website

Symbol: KALA

Recent Price: $6.87

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Mark T. Iwicki

Sector: Healthcare

Employees: 43

Address: 1167 Massachusetts Avenue, Arlington, MA 02476

Phone: 781 996 5252

Last updated: 2024-12-31

Kiora Pharmaceuticals, Inc.

Market Cap: Lowest

Employees: Lowest

KIO-301

Kiora Pharmaceuticals, Inc. develops therapies for ophthalmic diseases, with lead product KIO-301 in Phase 1 trial for vision restoration in degenerative retinal diseases and other products in trials for conditions like rheumatoid arthritis-related ocular issues and corneal wound repair.

Tags: clinical trials, ophthalmic diseases, ophthalmology, pharmaceuticals, vision restoration

Website

Symbol: KPRX

Recent Price: $3.30

Industry: Biotechnology

CEO: Dr. Brian M. Strem Ph.D.

Sector: Healthcare

Employees: 12

Address: 1371 East 2100 South, Salt Lake City, UT 84105

Phone: 781 788 8869

Last updated: 2024-12-31

Ocugen, Inc.

Market Cap: Low

Employees: Low

OCU400, OCU410, OCU200

Ocugen, Inc. is a clinical-stage biopharmaceutical company focused on developing gene therapies to cure blindness diseases. Its product pipeline includes gene therapy candidates targeting various retinal diseases and other conditions.

Tags: biopharmaceutical, blindness diseases, gene therapy, retinal diseases, strategic partnership

Website

Symbol: OCGN

Recent Price: $0.81

Industry: Biotechnology

CEO: Dr. Shankar Musunuri M.B.A., Ph.D.

Sector: Healthcare

Employees: 65

Address: 263 Great Valley Parkway, Malvern, PA 19355

Phone: 484 328 4701

Last updated: 2024-12-31

Ocuphire Pharma, Inc.

Market Cap: Lowest

Employees: Lowest

Nyxol

Ocuphire Pharma, Inc. is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders.

Tags: biopharmaceutical, clinical trials, ophthalmic, refractive disorders, retinal disorders

Website

Symbol: OCUP

Recent Price: $1.17

Industry: Biotechnology

CEO: Mr. George Magrath M.B.A., M.D., M.S.

Sector: Healthcare

Employees: 14

Address: 37000 Grand River Avenue, Farmington Hills, MI 48335

Phone: 248 681 9815

Last updated: 2024-12-31

OptiNose, Inc.

Market Cap: Low

Employees: Low

XHANCE

Opti Nose, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for ear, nose, throat, and allergy specialists in the U.S. Their products include XHANCE for chronic rhinosinusitis with nasal polyps, and Onzetra Xsail, with ongoing developments like OPN-019.

Tags: Chronic Rhinosinusitis, Clinical Trials, EDS, ENT, Nasal Polyps, Pharmaceutical, Specialty Pharma

Website

Symbol: OPTN

Recent Price: $0.41

Industry: Drug Manufacturers - Specialty & Generic

CEO: Dr. Ramy A. Mahmoud M.D., M.P.H.

Sector: Healthcare

Employees: 132

Address: 1020 Stony Hill Road, Yardley, PA 19067

Phone: 267 364 3500

Leadership

Ramy A. Mahmoud, MD, MPH, CEO
Paul Spence, Chief Commercial Officer
Terry Kohler, Chief Financial Officer
Mike Marino, Chief Legal Officer
Anthony Krick, Chief Accounting Officer
John Messina, PharmD, Senior Vice President, Clinical Development and Medical Affairs
Michael C. Berkey, Vice President, Technical Operations
Karen E. Brophy, Chief Human Resources Officer
Ramona Lloyd, PhD, RAC, Senior Vice President, Regulatory & Quality
Jonathan Neely, Vice President, Investor Relations, and Business Development
R. John Fletcher, Chairman
Wilhelmus Groenhuysen, Chief Operating Officer
Sandra L. Helton, Director
Catherine E. Owen, Director
Tomas J. Heyman, Director
Dr. Eric Bednarski, Director
Dr. Kyle Dempsey, Director

Last updated: 2024-12-31

Ovid Therapeutics Inc.

Market Cap: Low

Employees: Lowest

OV101, OV329, OV350, OV882, OV815

Ovid Therapeutics Inc., a biopharmaceutical company based in New York, is dedicated to developing impactful medicines for neurological disorders. They have a range of drug candidates like OV101 and are involved in various clinical trials.

Tags: biopharmaceutical, clinical trials, medicine development, neurological disorders

Website

Symbol: OVID

Recent Price: $0.96

Industry: Biotechnology

CEO: Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.

Sector: Healthcare

Employees: 40

Address: 1460 Broadway, New York, NY 10036

Phone: 646 661 7661

Leadership

Jeremy M. Levin, D.Phil, MB BChir, Chief Executive Officer and Chairman
Meg Alexander, President and Chief Operating Officer
Zhong Zhong, Ph.D., Chief Scientific Officer
Jeffrey Rona, Chief Business and Financial Officer
Amanda Banks, M.D., Chief Development Officer
Julia Tsai, Ph.D., Senior Vice President of Clinical Development
Karen Bernstein, Ph.D., Director, Chair of the Compensation Committee, Member of the Audit and Nominating and Corporate Governance Committees
Barbara G. Duncan, MBA, Director, Chair of the Audit Committee, Member of the Nominating and Corporate Governance Committee
Bart Friedman, J.D., Lead Independent Director, Chair of the Nominating and Corporate Governance Committee, Member of the Audit and Compensation Committees
Michael Poole, M.D., FACP, Director, Member of the Audit and Compensation Committees
Kevin Fitzgerald, Ph.D., Director, Member of the Nominating and Corporate Governance Committee

Last updated: 2024-12-31

Sight Sciences, Inc.

Market Cap: Low

Employees: Low

OMNI Surgical System, Tear Care System

Sight Sciences, Inc., is a company focused on developing and commercializing surgical and nonsurgical technologies for treating eye diseases, including products like the OMNI Surgical System for glaucoma and Tear Care System for dry eye disease.

Tags: dry eye disease, eye diseases, glaucoma, healthcare, medical device, ophthalmic, technology

Website

Symbol: SGHT

Recent Price: $3.53

Industry: Medical - Devices

CEO: Mr. Paul Badawi

Sector: Healthcare

Employees: 214

Address: 4040 Campbell Avenue, Menlo Park, CA 94025

Phone: 877 266 1144

Last updated: 2024-12-31

Novanta Inc.

Market Cap: Highest

Employees: High

Photonics, Vision, and Precision Motion Components

Novanta Inc. designs and manufactures photonics, vision, and precision motion components and sub-systems, primarily serving original equipment manufacturers in medical and industrial markets.

Tags: Imaging, Industrial, Laser, Medical, Metrology, Photonics, Precision Motion, Vision

Website

Symbol: NOVT

Recent Price: $152.29

Industry: Hardware, Equipment & Parts

CEO: Mr. Matthijs Glastra

Sector: Technology

Employees: 2900

Address: 125 Middlesex Turnpike, Bedford, MA 01730

Phone: 781 266 5700

Last updated: 2024-12-31

Syntec Optics Holdings, Inc.

Market Cap: Lowest

Employees: Low

Integrated Optics

Syntec Optics Holdings, Inc. manufactures and supplies integrated optics for biomedical, defense, military, consumer, and other applications. Their offerings include camera modules, optical design services, precision machining, and a wide range of technologies for various innovative applications such as driverless cars and facial imaging.

Tags: biomedical, consumer applications, defense, integrated photonics, military, optics, precision machining

Website

Symbol: OPTX

Recent Price: $3.37

Industry: Hardware, Equipment & Parts

CEO: Mr. Al Kapoor

Sector: Technology

Employees: 148

Address: 515 Lee Road, Rochester, NY 14606

Phone: 585-768-2513

Last updated: 2024-12-31

AEye, Inc.

Market Cap: Lowest

Employees: Lowest

4Sight

AEye provides lidar systems designed to enhance vehicle autonomy, advanced driver-assistance systems, and robotic vision applications through its 4Sight Intelligent Sensing Platform.

Tags: Advanced Driver-Assistance Systems, Autonomous Applications, Intelligent Sensing, Lidar, Software-Configurable Lidar

Website

Symbol: LIDR

Recent Price: $1.69

Industry: Auto - Parts

CEO: Mr. Matthew Fisch

Sector: Consumer Cyclical

Employees: 60

Address: One Park Place, Dublin, CA 94568

Phone: 925 400 4366

Leadership

Matt Fisch, CEO and Chairman
Conor Tierney, CFO
Andrew Hughes, General Counsel
Erica Allen, Chief People Officer
Timothy J. Dunn, Lead Independent Director Chair, Audit Committee
Jon Husby, Director
Luis C. Dussan, Director
Prof. Dr. Bernd Gottschalk, Chair, Nominating & Corporate Governance Committee
Sue E. Zeifman, Chair, Compensation Committee
Private: Rear Admiral David S. Bill III, Advisory Board Member
Private: Jeff Clarke, Advisory Board Member
Private: Keith Dierkx, Advisory Board Member
Private: James Doty, MD, Advisory Board Member
Private: Elliot Garbus, Advisory Board Member
Private: Willie Gault, Advisory Board Member
Private: Jonathan Lauckner, Advisory Board Member
Private: Dr. Karl Thomas Neumann, Advisory Board Member
Private: Luke Schneider, Advisory Board Member
Private: Art Blanchford, Advisory Board Member
Private: Markus Lipinsky, Advisory Board Member
Private: Ulrich Weinmann, Advisory Board Member
Private: Andreas Renschler, Advisory Board Member
Private: Chuck Price, Advisory Board Member

Last updated: 2024-12-31

🔥🐔 BizChicken 🐔🔥

Companies Similar to Eyenovia, Inc.

Sign Up Today!

National Vision Holdings, Inc.

Eyenovia, Inc.

Leadership

Regeneron Pharmaceuticals, Inc.

Leadership

Precision Optics Corporation, Inc.

Glaukos Corporation

Bluejay Diagnostics, Inc.

EyeGate Pharmaceuticals, Inc.

Leadership

EyePoint Pharmaceuticals, Inc.

IRIDEX Corporation

iTeos Therapeutics, Inc.

Leadership

Kala Pharmaceuticals, Inc.

Kiora Pharmaceuticals, Inc.

Ocugen, Inc.

Ocuphire Pharma, Inc.

OptiNose, Inc.

Leadership

Ovid Therapeutics Inc.

Leadership

Sight Sciences, Inc.

Novanta Inc.

Syntec Optics Holdings, Inc.

AEye, Inc.

Leadership

Choose Your Sign-In Method